Morimoto, Akira <br/><br/>
Early blastic transformation following complete cytogenetic response in a pediatric chronic myeloid leukemia patient treated with imatinib mesylate.  [electronic resource] 

 -  Journal of pediatric hematology/oncology  May 2004 
 - 320-2 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1077-4114 
<br/><br/><label>Standard No.: </label>10.1097/00043426-200405000-00013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Benzamides<br/>Blast Crisis--etiology<br/>Cytogenetic Analysis<br/>Disease-Free Survival<br/>Hematopoietic Stem Cell Transplantation<br/>Histocompatibility<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myeloid, Chronic-Phase--drug therapy<br/>Lymphocyte Activation<br/>Male<br/>Piperazines--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Recurrence<br/>Remission Induction--methods<br/>Transplantation, Homologous